These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20462290)

  • 1. A pressure model of immune response to mycobacterium tuberculosis infection in several space dimensions.
    Clarelli F; Natalini R
    Math Biosci Eng; 2010 Apr; 7(2):277-300. PubMed ID: 20462290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage response to Mycobacterium tuberculosis infection.
    Gammack D; Doering CR; Kirschner DE
    J Math Biol; 2004 Feb; 48(2):218-42. PubMed ID: 14745511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Granulomas in Response to Infection in the Lung.
    Hao W; Schlesinger LS; Friedman A
    PLoS One; 2016; 11(3):e0148738. PubMed ID: 26986986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling intercellular interactions in early Mycobacterium infection.
    Warrender C; Forrest S; Koster F
    Bull Math Biol; 2006 Nov; 68(8):2233-61. PubMed ID: 17086496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model.
    Segovia-Juarez JL; Ganguli S; Kirschner D
    J Theor Biol; 2004 Dec; 231(3):357-76. PubMed ID: 15501468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model for cellular immunology of tuberculosis.
    Ibarguen-Mondragon E; Esteva L; Chávez-Galán L
    Math Biosci Eng; 2011 Oct; 8(4):973-86. PubMed ID: 21936595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interactions of sensitive and resistant Mycobacterium tuberculosis to antibiotics.
    Ibargüen-Mondragón E; Esteva L
    Math Biosci; 2013 Nov; 246(1):84-93. PubMed ID: 23958384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease.
    Cardona PJ
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):7-14. PubMed ID: 20049645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of pathogenic mycobacteria with the host immune system.
    Houben EN; Nguyen L; Pieters J
    Curr Opin Microbiol; 2006 Feb; 9(1):76-85. PubMed ID: 16406837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach.
    Sershen CL; Plimpton SJ; May EE
    Front Cell Infect Microbiol; 2016; 6():6. PubMed ID: 26913242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human immune response to Mycobacterium tuberculosis in lung and lymph node.
    Marino S; Kirschner DE
    J Theor Biol; 2004 Apr; 227(4):463-86. PubMed ID: 15038983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.
    Cohen SB; Gern BH; Delahaye JL; Adams KN; Plumlee CR; Winkler JK; Sherman DR; Gerner MY; Urdahl KB
    Cell Host Microbe; 2018 Sep; 24(3):439-446.e4. PubMed ID: 30146391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune responses to M. tuberculosis infection.
    Natarajan K; Kundu M; Sharma P; Basu J
    Tuberculosis (Edinb); 2011 Sep; 91(5):427-31. PubMed ID: 21550855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages.
    Hirsch CS; Ellner JJ; Russell DG; Rich EA
    J Immunol; 1994 Jan; 152(2):743-53. PubMed ID: 8283049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Badewa AP; Quinton LJ; Shellito JE; Mason CM
    Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.
    Ordway D; Higgins DM; Sanchez-Campillo J; Spencer JS; Henao-Tamayo M; Harton M; Orme IM; Gonzalez Juarrero M
    J Leukoc Biol; 2007 Nov; 82(5):1221-9. PubMed ID: 17699612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection.
    Català M; Prats C; López D; Cardona PJ; Alonso S
    PLoS One; 2020; 15(9):e0239289. PubMed ID: 32936814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A delicate dance: host response to mycobacteria.
    Huynh KK; Joshi SA; Brown EJ
    Curr Opin Immunol; 2011 Aug; 23(4):464-72. PubMed ID: 21726990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.